BWX Technologies, Inc. (NYSE:BWXT) Q3 2021 Earnings Conference Call November 1, 2021 5:00 PM ET Company Participants Mark Kratz - Vice President, Investor Relations Rex Geveden - President and Chief Executive Officer David Black - Senior Vice President and Chief Financial Officer Conference Call Participants Peter Arment - Baird Pete Skibitski - Alembic Global Bob Labick - CJS Securities Michael Ciarmoli - Truist David Strauss - Barclays Ronald Epstein - Bank of America Operator Ladies and gentlemen, welcom ...

Table of Contents | --- | --- | |-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________________________________ | | FORM 10-Q | | (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF T ...

Financial Data and Key Metrics Changes - The company reported earnings of $0.62 per share on revenue exceeding $0.5 billion, indicating a year-to-date earnings performance in line with expectations despite a comparative decline [5][30] - Second quarter revenue was $505 million, approximately even with the previous year, with strong increases in the Nuclear Power Group offset by declines in Nuclear Operations and Nuclear Services [29] - Year-to-date consolidated revenue was down 1%, and earnings per share decreased by 10% compared to a robust first half in 2020 [31] Business Line Data and Key Metrics Changes - The Nuclear Operations Group generated $381 million in revenue, down about 7% year-over-year, primarily due to lower long lead material production [32] - The Nuclear Power Group saw a 50% increase in second quarter revenue to $102 million, driven by higher field service activity and a strong rebound in BWXT Medical, which was up nearly 60% [35] - The Nuclear Services Group reported $5.8 million in operating income for the second quarter, showing improvement from the previous year, with expectations for strong second half results [38] Market Data and Key Metrics Changes - The medical business in Canada returned to pre-pandemic levels with 60% topline growth in the second quarter, expected to continue through 2021 [10] - The company anticipates significant income growth in the Nuclear Services segment with new awards expected later this year [13] Company Strategy and Development Direction - The company is focused on achieving key milestones to position itself for continued growth, including advancements in nuclear microreactor development and partnerships with NASA and the Department of Energy [15][18] - BWXT plans to participate in the commercial nuclear market by supporting advanced reactor development through supply chain involvement and proprietary technology investments [23][25] - The company is optimistic about the future of nuclear energy, particularly in light of government support for nuclear energy research and development [20][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in a strong second half of 2021, driven by increased production volume and favorable contract adjustments [41][68] - The company is monitoring government budget developments and is encouraged by bipartisan support for naval nuclear fleet recapitalization [20][22] - Management highlighted the importance of maintaining flexibility in the balance sheet to capitalize on future growth opportunities [43][46] Other Important Information - The company reiterated its 2021 guidance while making minor updates based on year-to-date actuals, including anticipated higher development and commercialization expenses related to the Tech 99 generator product line [39] - BWXT plans to host an Investor Day on November 16th to provide further insights into growth initiatives and strategies [48] Q&A Session Summary Question: Discussion on Moly-Technetium and FDA submission process - Management detailed the steps necessary to complete the radio farm line and the process for FDA submission, including the installation of sterilization technology and running cold chemistry tests [49][50] Question: Timeline for FDA review - The company is requesting a priority review from the FDA, with a typical timeline of nine months for approval [55] Question: Cost competitiveness of small modular reactors - Management acknowledged the current high costs of small modular reactors and emphasized the need to reduce costs to compete with other energy sources [57][58] Question: Hiring situation and labor market constraints - Management confirmed ongoing hiring efforts and expressed confidence in attracting quality applicants due to the company's strong visibility into its backlog [60][61] Question: Long lead items for Virginia class submarines - Management indicated that they are not currently planning for an additional Virginia class submarine but are prepared to accommodate it if needed [77][78] Question: Nuclear thermal propulsion program with NASA - Management provided updates on the development of nuclear thermal propulsion systems and expressed optimism about future demonstration missions [79][80]

| --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-----------------------------------|-------|-------|-------------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2021 Second Quarter Earnings Call | | | | | | | | | | | | | | | | | | Presentation | | | | | | | | | | | | Reported August 2 ...

[PART I – FINANCIAL INFORMATION](index=2&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) [Item 1. Condensed Consolidated Financial Statements](index=3&type=section&id=Item%201.%20Condensed%20Consolidated%20Financial%20Statements) The unaudited condensed consolidated financial statements for the period ended June 30, 2021, reflect asset growth, flat Q2 revenues with decreased net income, and stable operating cash flow alongside increased investing activities [Condensed Consolidated Balance Sheets](index=3&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) The balance sheets as of June 30, 2021, show total assets increased to $2.57 billion, total liabilities to $1.86 billion, and stockholders' equity to $709.1 million, reflecting changes in cash, property, and debt classification Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | June 30, 2021 | December 31, 2020 | | :--- | :--- | :--- | | **Total Current Assets** | $922,652 | $773,598 | | **Total Assets** | **$2,566,402** | **$2,293,503** | | **Total Current Liabilities** | $801,643 | $529,727 | | **Total Liabilities** | $1,857,315 | $1,675,735 | | **Total Stockholders' Equity** | $709,087 | $617,768 | [Condensed Consolidated Statements of Income](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) For Q2 2021, revenues remained flat at $505.1 million, while operating income decreased to $73.8 million and net income to $59.3 million, with similar trends observed for the six-month period Key Income Statement Data (in thousands, except per share amounts) | Metric | Q2 2021 | Q2 2020 | H1 2021 | H1 2020 | | :--- | :--- | :--- | :--- | :--- | | Revenues | $505,099 | $504,520 | $1,033,372 | $1,046,728 | | Operating Income | $73,751 | $82,434 | $156,165 | $180,701 | | Net Income Attributable to BWXT | $59,347 | $64,258 | $129,096 | $139,757 | | Diluted EPS | $0.62 | $0.67 | $1.35 | $1.46 | [Condensed Consolidated Statements of Comprehensive Income](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) Total comprehensive income for Q2 2021 increased to $67.4 million, primarily driven by favorable currency translation adjustments that offset lower net income, with a similar trend for the six-month period - **Favorable currency translation adjustments** were the **primary driver** of **higher comprehensive income** in both the three and six-month periods of 2021 compared to 2020, despite lower net income[27](index=27&type=chunk) [Condensed Consolidated Statements of Stockholders' Equity](index=7&type=section&id=Condensed%20Consolidated%20Statements%27%20Equity) Total stockholders' equity increased to $709.1 million as of June 30, 2021, primarily driven by net income, partially offset by dividends declared - The **primary drivers** for the change in stockholders' equity during the first half of 2021 were **net income and dividends declared**[29](index=29&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) For the first six months of 2021, net cash from operations slightly increased to $158.3 million, while investing activities used more cash at $169.6 million, and financing activities shifted to a $159.4 million inflow due to increased debt borrowings Six Months Ended June 30, Cash Flow Summary (in thousands) | Cash Flow Activity | 2021 | 2020 | | :--- | :--- | :--- | | Net Cash from Operating Activities | $158,323 | $155,630 | | Net Cash used in Investing Activities | ($169,602) | ($129,417) | | Net Cash from (used in) Financing Activities | $159,422 | ($50,367) | [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) The notes detail the company's three nuclear segments, revenue recognition methods, effective tax rate, recent debt issuance, and a total remaining performance obligation (backlog) of $4.85 billion - The company operates in **three reportable segments**: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group[37](index=37&type=chunk) Remaining Performance Obligations by Segment (in millions) | Segment | 2021 (Remainder) | 2022 | Thereafter | Total | | :--- | :--- | :--- | :--- | :--- | | Nuclear Operations Group | $825 | $1,235 | $2,073 | $4,133 | | Nuclear Power Group | $179 | $202 | $293 | $674 | | Nuclear Services Group | $36 | $6 | $0 | $42 | | **Total** | **$1,040** | **$1,443** | **$2,366** | **$4,849** | Segment Revenues and Operating Income - H1 2021 vs H1 2020 (in thousands) | Segment | Revenues H1 2021 | Revenues H1 2020 | Operating Income H1 2021 | Operating Income H1 2020 | | :--- | :--- | :--- | :--- | :--- | | Nuclear Operations Group | $783,410 | $834,027 | $143,517 | $176,331 | | Nuclear Power Group | $209,240 | $155,900 | $21,158 | $9,572 | | Nuclear Services Group | $55,617 | $70,093 | $11,507 | $10,522 | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=21&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management reported flat Q2 2021 revenues, a decline in operating income primarily from the Nuclear Operations Group, growth in backlog to $4.8 billion, and affirmed strong liquidity after recent debt refinancing, while managing COVID-19 impacts as an essential business [COVID-19 Assessment](index=23&type=section&id=COVID-19%20Assessment) Designated an essential business, the company continued operations with health precautions, utilizing government assistance including $21.4 million in deferred U.S. payroll taxes and $3.3 million from the Canada Emergency Wage Subsidy in Q2 2021 - The company was designated as an **essential business** in the U.S. and Canada, allowing for continued operations during the pandemic[113](index=113&type=chunk) - As of June 30, 2021, the company has deferred **$21.4 million** in U.S. payroll tax payments under the CARES Act[115](index=115&type=chunk) - The company recognized **$3.3 million** and **$4.2 million** of subsidies under the Canada Emergency Wage Subsidy (CEWS) during the three and six months ended June 30, 2021, respectively[115](index=115&type=chunk) [Consolidated Results of Operations](index=24&type=section&id=Consolidated%20Results%20of%20Operations) Consolidated revenues for Q2 2021 were flat, while operating income declined to $73.8 million, with similar trends for H1 2021 primarily due to lower Nuclear Operations Group performance partially offset by Nuclear Power Group growth Consolidated Results Summary (in thousands) | Metric | Q2 2021 | Q2 2020 | H1 2021 | H1 2020 | | :--- | :--- | :--- | :--- | :--- | | Revenues | $505,099 | $504,520 | $1,033,372 | $1,046,728 | | Operating Income | $73,751 | $82,434 | $156,165 | $180,701 | [Backlog](index=27&type=section&id=Backlog) Total company backlog increased to $4.85 billion at the end of Q2 2021, primarily driven by the Nuclear Operations Group, with an additional $1.5 billion in unexercised options not included Backlog by Segment (in millions) | Segment | June 30, 2021 | December 31, 2020 | | :--- | :--- | :--- | | Nuclear Operations Group | $4,133 | $3,659 | | Nuclear Power Group | $674 | $726 | | Nuclear Services Group | $42 | $21 | | **Total Backlog** | **$4,849** | **$4,406** | - In March 2021, the company received U.S. Government awards valued at a combined **$2.2 billion**, with approximately **$1.1 billion** added to backlog as of June 30, 2021[151](index=151&type=chunk) - An additional **$1.5 billion** in unexercised options was excluded from the backlog as of June 30, 2021[152](index=152&type=chunk) [Liquidity and Capital Resources](index=28&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains strong liquidity with $720.5 million available under its credit facility, having issued $400 million in new senior notes and subsequently redeemed older notes, ensuring sufficient funding for the next 12 months - The company has a **$750 million** senior secured revolving credit facility maturing in March 2025, with **$720.5 million** available as of June 30, 2021[153](index=153&type=chunk)[161](index=161&type=chunk) - In April 2021, the company issued **$400 million** of 4.125% Senior Notes due 2029[73](index=73&type=chunk)[170](index=170&type=chunk) - On July 15, 2021, after the quarter ended, the company redeemed the entire **$400 million** principal of its 5.375% Senior Notes due 2026, incurring a **$10.8 million** premium[78](index=78&type=chunk)[164](index=164&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=31&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reported no material changes to its market risk exposures compared to those disclosed in its 2020 Annual Report on Form 10-K - There have been **no material changes** to the company's market risk exposures since the 2020 10-K filing[185](index=185&type=chunk) [Item 4. Controls and Procedures](index=31&type=section&id=Item%204.%20Controls%20and%20Procedures) The company's disclosure controls and procedures were deemed effective as of June 30, 2021, with no material changes to internal control over financial reporting during the quarter - The CEO and CFO concluded that the company's disclosure controls and procedures were **effective** as of June 30, 2021[187](index=187&type=chunk) - **No material changes** to internal control over financial reporting occurred during the second quarter of 2021[187](index=187&type=chunk) [PART II – OTHER INFORMATION](index=34&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) [Item 1. Legal Proceedings](index=34&type=section&id=Item%201.%20Legal%20Proceedings) The company reported no material legal proceedings or contingencies for the period, as referenced in Note 6 of its financial statements - There were **no material legal proceedings or contingencies** reported for the period[80](index=80&type=chunk)[190](index=190&type=chunk) [Item 1A. Risk Factors](index=34&type=section&id=Item%201A.%20Risk%20Factors) The company reported no material changes to the risk factors previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2020 - **No material changes** to risk factors were reported from those disclosed in the 2020 10-K[191](index=191&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=34&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) During Q2 2021, the company repurchased 874 shares for employee tax obligations, and the Board authorized a new $500 million share repurchase program with no expiration date - On April 30, 2021, the Board of Directors authorized a new share repurchase program for up to **$500 million** with no expiration date[193](index=193&type=chunk) - **No shares were repurchased** during Q2 2021 as part of the publicly announced plans; the **874 shares** repurchased were to satisfy employee tax obligations[193](index=193&type=chunk) [Item 6. Exhibits](index=35&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including the indenture for the 4.125% Senior Notes due 2029 and required CEO and CFO certifications - **Key exhibits** filed include the indenture for the new Senior Notes due 2029 and required certifications by the CEO and CFO[195](index=195&type=chunk)

| --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|------------------------------------------------|-------|----------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2021 First Quarter Earnings Call Presentation | | | | | | | | | | | | | | | | | | | | | | | | | | Reported May 3, 2021 | 2 Forward-Looking Statements Disclaimer BWX Technologies, Inc. ("BWXT") cautions that statement ...

BWX Technologies, Inc. (NOW) Q1 2021 Earnings Conference Call May 4, 2021 9:00 AM ET Company Participants Mark Kratz - VP, Investor Relations Rex Geveden - President and Chief Executive Officer David Black - Senior Vice President and Chief Financial Officer Conference Call Participants Robert Spingarn - Credit Suisse Bob Labick - CJS Securities Peter Arment - Baird Pete Skibitski - Alembic Global Michael Ciarmoli - Truist Ron Epstein - Bank of America Operator Ladies and gentlemen, welcome to BWX Technologi ...

Table of Contents | --- | --- | |------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Washington, D.C. 20549 | SECURITIES AND EXCHANGE COMMISSION _________________________________________________________________________________________________________________________________ | | FORM 10-Q | | (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT ...

| --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-----------------------------------|-------|----------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2020 Fourth Quarter Earnings Call | | | | | | | | | Presentation | | | | | | | | | | | | | | | | | | | | Reported February 22, 2021 | | > 2 Forward-Looking S ...

BWX Technologies, Inc. (NYSE:BWXT) Q4 2020 Earnings Conference Call February 23, 2021 9:00 AM ET Company Participants Mark Kratz - Director, Investor Relations Rex Geveden - President and Chief Executive Officer David Black - Senior Vice President and Chief Financial Officer Conference Call Participants Carter Copeland - Melius Research Bob Labick - CJS Securities Pete Skibitski - Alembic Global Robert Spingarn - Credit Suisse Peter Arment - Baird Michael Ciarmoli - Truist Securities Ron Epstein - Bank of ...